Show simple item record

dc.creatorMijanović, Olja
dc.creatorBranković, Ana
dc.creatorPanin, Alexander N.
dc.creatorSavchuk, Solomiia
dc.creatorTimashev, Peter
dc.creatorUlasov, llya
dc.creatorLesniak, Maciej S.
dc.date.accessioned2019-03-21T16:12:29Z
dc.date.accessioned2019-03-26T20:47:46Z
dc.date.available2020-02-20
dc.date.available2020-02-20
dc.date.issued2019
dc.identifier.issn0304-3835
dc.identifier.urihttp://jakov.kpu.edu.rs/handle/123456789/891
dc.description.abstractClinical, biochemical and molecular biology studies have identified lysosome-encapsulated cellular proteases as critical risk factors for cancer progression. Cathepsins represent a group of such proteases aimed at maintenance of cellular homeostasis. Nevertheless, recent reports suggest that Cathepsin B executes other cellular programs such as controlling tumor growth, migration, invasion, angiogenesis, and metastases development. In fact, elevated levels of Cathepsins are found under different pathological conditions including inflammation, infection, neurodegenerative disease, and cancer. Furthermore, the discovery of Cathepsin B secretion and function as an extracellular matrix protein has broadened our appreciation for the impact of Cathepsin B on cancer progression. Underneath a façade of an intracellular protease with limited therapeutic potential hides a central role of cathepsins in extracellular functions. Moreover, this role is incredibly diverse from one condition to the next – from driving caspase-dependent apoptosis to facilitating tumor neovascularization and metastasis. Here we discuss the role of Cathepsin B in the oncogenic process and perspective the use of Cathepsin B for diagnostic and therapeutic applications.en
dc.publisherElsevier
dc.rightsembargoedAccess
dc.sourceCancer Letters
dc.subjectautophagyen
dc.subjectcathepsin Ben
dc.subjectmigrationen
dc.subjecttumoren
dc.titleCathepsin B: A sellsword of cancer progressionen
dc.typecontributionToPeriodical
dc.rights.licenseBY-NC-ND
dcterms.abstractБранковић, Aна; Мијановић, Оља; Панин, Aлеxандер Н.; Савцхук, Соломииа; Тимасхев, Петер; Уласов, ллyа; Лесниак, Мациеј С.;
dc.citation.volume449
dc.citation.spage207
dc.citation.epage214
dc.citation.other449: 207-214
dc.citation.rankM21
dc.description.otherThis is the peer-reviewed version of the article: Mijanović, Olja, Ana Branković, Alexander N. Panin, Solomiia Savchuk, Peter Timashev, Ilya Ulasov, and Maciej S. Lesniak. 2019. ‘Cathepsin B: A Sellsword of Cancer Progression’. Cancer Letters 449 (May): 207–14. [https://doi.org/10.1016/j.canlet.2019.02.035].
dc.identifier.doi10.1016/j.canlet.2019.02.035
dc.identifier.fulltexthttp://jakov.kpu.edu.rs/bitstream/id/1997/10.1016@j.canlet.2019.02.035.pdf
dc.identifier.scopus2-s2.0-85062032514
dc.identifier.wos000463130200021
dc.type.versionacceptedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record